COURSE DESCRIPTION:

A multidisciplinary team approach in oral medicine in cancer care is fostered through peer-to-peer discussion and collaboration. 
A team discussion addressing appropriate and timely identification of oral precancers (i.e.  leukoplakia) and/or oral diseases will bridge gaps in access to oral medicine specialist and reduce the incidence and severity of complications attributed to cancer care therapy and illness. 
This conference will enhance the growth at Miami Cancer Institute and Lynn Cancer Institute in partnership with local dental community to support medically complex patients to improve patient’s outcomes.  

TARGET AUDIENCE:
Dentists, Oral & Maxillofacial Surgeons, Hematology Oncologists/Medical Oncologists, Surgical Oncologists, Radiation Oncologists, General Surgeons, Pathologists, Radiologists, Advanced Practice Registered Nurses, Physician Assistants/Physician Associates, Oncology Dental Assistants, Nurses, Social Workers, Pharmacists, and other healthcare personnel involved in the care of oral precancer patient.
 
EDUCATIONAL OBJECTIVES:

•    Improve clinical decision making, clinical outcomes, and patient experience via a multidisciplinary team approach. 
•    Apply prospective patient care management strategies, interpret national treatment guidelines, evaluate options and eligibility for clinical research studies, and integrate supportive care services to enhance multidisciplinary decision-making.
•    Develop a comprehensive treatment plan to help detect oral diseases leveraging clinical characteristics and evaluation, clinical pathology testing results, and utilization of visualization tools for an individualize approach to treatment.

FACULTY:

Alessandro Villa, DDS, Ph.D., MPH
Chief of Oral Medicine, Oral Oncology and Dentistry
Miami Cancer Institute

Alessandro Villa, DDS, Ph.D., MPH, faculty for this activity has received grant/ research support from Mairagtx, Merck, Mureva. He is a consultant for Afyx Therapeutics, Lipella Pharmaceuticals and K Pharm. He receives royalties from UpToDate.
 All of the relevant financial relationships listed for this individual have been mitigated.

DMT project managers and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*:

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

ACCREDITATION:
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.    

Baptist Health South Florida designates these live activities for a maximum of 1 AMA PRA Category 1 Credit™ each. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

These activities have been approved for 1 credit hour, CE Broker Course #20-633178 by the Florida Boards of Medicine and Osteopathic Medicine.

American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME - Complex General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system.